Becton raises debt for CareFusion buy; Researchers find biomarkers for TB treatment success;

@FierceMedDev: Welch Allyn partners with LKC to distribute novel diabetic retinopathy device. Story | Follow @FierceMedDev

@EmilyWFierce: Covidien loses battle in patent war with J&J as top U.S. patent court throws out $176M award. More | Follow @EmilyWFierce

> Becton Dickinson ($BDX) will offer senior unsecured notes, with proceeds of the offering going toward the acquisition of CareFusion. Release

> NIH researchers find PET and CT scans as successful biomarkers to predict antibiotic success in TB patients. Release

> Ekso Bionics raised $22.8 million of its $30.3 million goal from 157 investors in a funding round. SEC filing

> U.K. researchers found that teens with hearing impairment detected during infancy had higher reading comprehension than teens whose impairment was not detected until later in life. Story

Biotech News

@FierceBiotech: Does the 'sharing economy' have a place in biotech? More | Follow @FierceBiotech

@JohnCFierce: $GSK news blew away the rest of the yr's top 10 reports in terms of readers. And it was all industry/investors. Story | Follow @JohnCFierce

@DamianFierce: Sorting through $PFE for $BMY tweets is like a survey course in the epidemiology of bio Twitter BS. Highly recommended. | Follow @DamianFierce

> Juno expands its CAR-T arsenal with latest immuno-oncology deal. News

> Does the 'sharing economy' have a place in biotech? Article

> U.K. biotech Evgen plots a $31M IPO to push its vegetable-derived pipeline. More

Pharma News

@FiercePharma: Sanofi Chairman says French tax burden a killer for attracting execs. Story | Follow @FiercePharma

@EricPFierce: ICYMI: Sanofi, Viehbacher accused of kickback scheme in whistleblower suit. Article | Follow @EricPFierce

@CarlyHFierce: Reckitt CEO, nearing spinoff, thinks he can outdo Big Pharma in consumer health. Story | Follow @CarlyHFierce

> GSK changes its tune, plans to hold on to aging drug portfolio. More

> More turmoil in top ranks of Sanofi's diabetes business. News

> Reckitt CEO, nearing spinoff, thinks he can outdo Big Pharma in consumer health. Story

Suggested Articles

Adaptive Biotechnologies is planning a $200 million IPO to help power its sequencing tests aimed at the body’s immune system and related therapies.

Abbott’s new diabetes test provides A1c results in three minutes, allowing clinicians to develop care plans within a single office visit.

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.